(Q35576272)

8 August 2017

title

Radiation dose intensification in limited-stage small-cell lung cancer (English)

1 reference

8 August 2017

Radiation Dose Intensification in Limited-Stage Small-Cell Lung Cancer (English)

1 reference

https://api.crossref.org/works/10.3816/CLC.2003.N.013

28 March 2024

1 reference

https://api.crossref.org/works/10.3816/CLC.2003.N.013

28 March 2024

author name string

Panos Fidias

2

1 reference

8 August 2017

Kevin S. Roof

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14599300

28 March 2024

Thomas J. Lynch

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14599300

28 March 2024

Noah C. Choi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14599300

28 March 2024

language of work or name

English

0 references

publication date

1 May 2003

1 reference

full work available at URL

8 August 2017

https://api.elsevier.com/content/article/PII:S1525730411703035?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.3816/CLC.2003.N.013

https://api.elsevier.com/content/article/PII:S1525730411703035?httpAccept=text/plain

28 March 2024

1 reference

https://api.crossref.org/works/10.3816/CLC.2003.N.013

28 March 2024

1 reference

8 August 2017

volume

4

1 reference

8 August 2017

issue

6

1 reference

8 August 2017

page(s)

339-346

1 reference

Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial.

8 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.3816/CLC.2003.N.013

Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial.

28 March 2024

2

1 reference

https://api.crossref.org/works/10.3816/CLC.2003.N.013

Improved survival with preoperative radiotherapy in resectable rectal cancer

28 March 2024

3

1 reference

https://api.crossref.org/works/10.3816/CLC.2003.N.013

Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide

28 March 2024

4

1 reference

https://api.crossref.org/works/10.3816/CLC.2003.N.013

Importance of radiation dose in achieving improved loco-regional tumor control in limited stage small-cell lung carcinoma: an update

28 March 2024

5

1 reference

https://api.crossref.org/works/10.3816/CLC.2003.N.013

Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent chemotherapy for limited-stage small-cell lung cancer

28 March 2024

6

1 reference

https://api.crossref.org/works/10.3816/CLC.2003.N.013

The effect of dose of thoracic irradiation on recurrence in patients with limited stage small cell lung cancer. Initial results of a Canadian Multicenter Randomized Trial

28 March 2024

8

1 reference

https://api.crossref.org/works/10.3816/CLC.2003.N.013

Improved local control of thoracic disease in small cell lung cancer with higher dose thoracic irradiation and cyclic chemotherapy

28 March 2024

9

1 reference

https://api.crossref.org/works/10.3816/CLC.2003.N.013

Medical Research Council comparative trial of surgery and radiotherapy for primary treatment of small-celled or oat-celled carcinoma of bronchus. Ten-year follow-up

28 March 2024

10

1 reference

https://api.crossref.org/works/10.3816/CLC.2003.N.013

The Feasibility of Adjuvant Surgery in Limited-Stage Small Cell Carcinoma: A Prospective Evaluation

28 March 2024

12

1 reference

https://api.crossref.org/works/10.3816/CLC.2003.N.013

A prospective randomized trial to determine the benefit of surgical resection of residual disease following response of small cell lung cancer to combination chemotherapy

28 March 2024

14

1 reference

https://api.crossref.org/works/10.3816/CLC.2003.N.013

The role of surgery in the management of selected patients with small-cell carcinoma of the lung

28 March 2024

15

1 reference

https://api.crossref.org/works/10.3816/CLC.2003.N.013

Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung

28 March 2024

16

1 reference

https://api.crossref.org/works/10.3816/CLC.2003.N.013

Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104.

28 March 2024

17

1 reference

https://api.crossref.org/works/10.3816/CLC.2003.N.013

Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group

28 March 2024

18

1 reference

https://api.crossref.org/works/10.3816/CLC.2003.N.013

Chemotherapy versus chemotherapy plus irradiation in limited small cell lung cancer. Results of a controlled trial with 5 years follow-up

28 March 2024

19

1 reference

https://api.crossref.org/works/10.3816/CLC.2003.N.013

Radiotherapy in small cell cancer of the lung treated with combination chemotherapy: a controlled trial

28 March 2024

20

1 reference

https://api.crossref.org/works/10.3816/CLC.2003.N.013

A meta-analysis of thoracic radiotherapy for small-cell lung cancer

28 March 2024

21

1 reference

https://api.crossref.org/works/10.3816/CLC.2003.N.013

Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis

28 March 2024

22

1 reference

https://api.crossref.org/works/10.3816/CLC.2003.N.013

Limited-stage small cell lung cancer: local failure after chemotherapy and radiation therapy

28 March 2024

23

1 reference

https://api.crossref.org/works/10.3816/CLC.2003.N.013

Phase III comparison of twice-daily split-course irradiation versus once-daily irradiation for patients with limited stage small-cell lung carcinoma

28 March 2024

24

1 reference

https://api.crossref.org/works/10.3816/CLC.2003.N.013

A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9

28 March 2024

28

1 reference

https://api.crossref.org/works/10.3816/CLC.2003.N.013

A quality-adjusted reanalysis of a Phase III trial comparing once-daily thoracic radiation vs. twice-daily thoracic radiation in patients with limited-stage small-cell lung cancer(1).

28 March 2024

29

1 reference

https://api.crossref.org/works/10.3816/CLC.2003.N.013

Radiation pneumonitis following combined modality therapy for lung cancer: analysis of prognostic factors

28 March 2024

31

1 reference

https://api.crossref.org/works/10.3816/CLC.2003.N.013

Correlation between lung fibrosis and radiation therapy dose after concurrent radiation therapy and chemotherapy for limited small cell lung cancer

28 March 2024

32

1 reference

https://api.crossref.org/works/10.3816/CLC.2003.N.013

Factors influencing the development of lung fibrosis after chemoradiation for small cell carcinoma of the lung: evidence for inherent interindividual variation

28 March 2024

33

1 reference

https://api.crossref.org/works/10.3816/CLC.2003.N.013

Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer

28 March 2024

34

1 reference

https://api.crossref.org/works/10.3816/CLC.2003.N.013

28 March 2024

Identifiers

1 reference

release_gic6ifaigrbcxdxmsc5dl7qane

8 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/gic6ifaigrbcxdxmsc5dl7qane

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference